134 related articles for article (PubMed ID: 22939281)
1. Predictive value of negative cone margin status for risk of residual disease among women with cervical adenocarcinoma in situ.
Kietpeerakool C; Khunamornpong S; Srisomboon J; Kasunan A; Sribanditmongkol N; Siriaungkul S
Int J Gynaecol Obstet; 2012 Dec; 119(3):266-9. PubMed ID: 22939281
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting residual lesion in women with cervical adenocarcinoma in situ after cone excisional biopsy.
Srisomboon J; Kietpeerakool C; Suprasert P; Siriaunkgul S; Khunamornpong S; Prompittayarat W
Asian Pac J Cancer Prev; 2007; 8(2):225-8. PubMed ID: 17696736
[TBL] [Abstract][Full Text] [Related]
3. Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
DeSimone CP; Day ME; Dietrich CS; Tovar MM; Modesitt SC
J Reprod Med; 2011; 56(9-10):376-80. PubMed ID: 22010519
[TBL] [Abstract][Full Text] [Related]
4. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
Tierney KE; Lin PS; Amezcua C; Matsuo K; Ye W; Felix JC; Roman LD
Am J Obstet Gynecol; 2014 Apr; 210(4):366.e1-366.e5. PubMed ID: 24370689
[TBL] [Abstract][Full Text] [Related]
5. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
Denehy TR; Gregori CA; Breen JL
Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
[TBL] [Abstract][Full Text] [Related]
6. Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status.
Salani R; Puri I; Bristow RE
Am J Obstet Gynecol; 2009 Feb; 200(2):182.e1-5. PubMed ID: 19019325
[TBL] [Abstract][Full Text] [Related]
7. Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ.
Lea JS; Shin CH; Sheets EE; Coleman RL; Gehrig PA; Duska LR; Miller DS; Schorge JO
Gynecol Oncol; 2002 Oct; 87(1):129-32. PubMed ID: 12468353
[TBL] [Abstract][Full Text] [Related]
8. Fertility-sparing treatment in younger women with adenocarcinoma in situ of the cervix.
van Hanegem N; Barroilhet LM; Nucci MR; Bernstein M; Feldman S
Gynecol Oncol; 2012 Jan; 124(1):72-7. PubMed ID: 22030403
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma in situ of the cervix: management and outcome.
Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
[TBL] [Abstract][Full Text] [Related]
10. Cervical adenocarcinoma in situ: the predictive value of conization margin status.
Young JL; Jazaeri AA; Lachance JA; Stoler MH; Irvin WP; Rice LW; Andersen WA; Modesitt SC
Am J Obstet Gynecol; 2007 Aug; 197(2):195.e1-7; discussion 195.e7-8. PubMed ID: 17689647
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cold knife cone biopsy and loop electrosurgical excision procedure in the management of cervical adenocarcinoma in situ: What is the gold standard?
Munro A; Leung Y; Spilsbury K; Stewart CJ; Semmens J; Codde J; Williams V; O'Leary P; Steel N; Cohen P
Gynecol Oncol; 2015 May; 137(2):258-63. PubMed ID: 25769659
[TBL] [Abstract][Full Text] [Related]
12. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
Poynor EA; Barakat RR; Hoskins WJ
Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
[TBL] [Abstract][Full Text] [Related]
13. Conservative management of adenocarcinoma in situ of the cervix.
Shin CH; Schorge JO; Lee KR; Sheets EE
Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
[TBL] [Abstract][Full Text] [Related]
14. Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix.
Costales AB; Milbourne AM; Rhodes HE; Munsell MF; Wallbillich JJ; Brown J; Frumovitz M; Ramondetta LM; Schmeler KM
Gynecol Oncol; 2013 Jun; 129(3):513-6. PubMed ID: 23541795
[TBL] [Abstract][Full Text] [Related]
15. Management of adenocarcinoma in situ of the uterine cervix: a comparison of loop electrosurgical excision procedure and cold knife conization.
Latif NA; Neubauer NL; Helenowski IB; Lurain JR
J Low Genit Tract Dis; 2015 Apr; 19(2):97-102. PubMed ID: 25089550
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of loop electrosurgical excisional procedure in diagnosis and treatment of cervical adenocarcinoma in situ and invasive cervical adenocarcinoma].
Song Y; Wang Q; Sui L; Gao SJ
Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):178-182. PubMed ID: 29609232
[No Abstract] [Full Text] [Related]
17. Is electrosurgical loop excision with negative margins sufficient treatment for cervical ACIS?
Bryson P; Stulberg R; Shepherd L; McLelland K; Jeffrey J
Gynecol Oncol; 2004 May; 93(2):465-8. PubMed ID: 15099963
[TBL] [Abstract][Full Text] [Related]
18. Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological margins.
Munro A; Codde J; Spilsbury K; Stewart CJ; Steel N; Leung Y; Tan J; Salfinger SG; Mohan GR; Semmens JB; Cohen PA
Acta Obstet Gynecol Scand; 2017 Apr; 96(4):432-437. PubMed ID: 28181670
[TBL] [Abstract][Full Text] [Related]
19. [Risk stratified management of cervical adenocarcinoma in situ based on cone margin state].
Huang SS; Sui L; Chen LM; Zhang HW; Tao X
Zhonghua Fu Chan Ke Za Zhi; 2021 Sep; 56(9):622-629. PubMed ID: 34547863
[No Abstract] [Full Text] [Related]
20. Management of adenocarcinoma in situ (ACIS) of the uteri cervix--a clinical dilemma.
Tay EH; Yew WS; Ho TH
Singapore Med J; 1999 Jan; 40(1):36-9. PubMed ID: 10361484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
